Skip to content

Stroke Prognosis in Intensive CarE

Stroke Prognosis in Intensive CarE - The SPICE Registry

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03335995
Acronym
SPICE
Enrollment
364
Registered
2017-11-08
Start date
2017-10-18
Completion date
2020-11-18
Last updated
2025-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Stroke Patients Requiring Invasive Mechanical Ventilation

Keywords

mechanical invasive ventilation, course of the care, prognosis, stroke

Brief summary

The S.P.I.C.E registry is an investigator-initiated prospective multicenter cohort study which will be conducted in 35 ICUS in the Paris area.The aim of the study is to determine the trajectory of acute stroke patients requiring invasive mechanical ventilation, focusing on functional outcomes at 3 months and 1 year following ICU admission. This project is funded by the French Agence Régionale de Santé (ARS).

Interventions

None listed

Sponsors

Institut National de la Santé Et de la Recherche Médicale, France
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Age\>18 years * Acute stroke (acute ischaemic stroke, brain hemorrhage, subarachnoid hemorrhage). The stroke diagnosis date is defined by the date of the initial brain imaging (TDM or MRI). * Admitted to ICU within 7 days before or after the diagnosis of stroke. * Requiring invasive mechanical ventilation in ICU for more than 24 hours.

Exclusion criteria

* Traumatic causes of stroke * Refusal of the patient, or his reliable person, to participate in the study. * Privation of liberty by administrative or judicial decision

Design outcomes

Primary

MeasureTime frameDescription
Functional outcomeOne yearScore on the modified Rankin scale (a disability score that ranges from 0 \[no symptoms\] to 6 \[death\]). Patients will be classified as good outcome (score of 0-3) or poor outcome (score of 4-6, indicating severe disability or death).

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026